These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 39133316
21. Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen (68 Ga-PSMA) positron-emission/computed tomography after radical prostatectomy with pathological node-positive extended lymph node dissection. Huits TH, Luiting HB, van der Poel HG, Nandurkar R, Donswijk M, Schaake E, Vogel W, Roobol MJ, Wit E, Stricker P, Emmett L, van Leeuwen PJ. BJU Int; 2020 Jun; 125(6):876-883. PubMed ID: 32181951 [Abstract] [Full Text] [Related]
22. Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature. Luiting HB, van Leeuwen PJ, Busstra MB, Brabander T, van der Poel HG, Donswijk ML, Vis AN, Emmett L, Stricker PD, Roobol MJ. BJU Int; 2020 Feb; 125(2):206-214. PubMed ID: 31680398 [Abstract] [Full Text] [Related]
23. Regional Lymph Node Metastasis on Prostate Specific Membrane Antigen Positron Emission Tomography Correlates with Decreased Biochemical Recurrence-Free and Therapy-Free Survival after Radical Prostatectomy: A Retrospective Single-Center Single-Arm Observational Study. Amiel T, Würnschimmel C, Heck M, Horn T, Nguyen N, Budäus L, Knipper S, Wenzel M, Rauscher I, Eiber M, Wang H, Maurer T. J Urol; 2021 Jun; 205(6):1663-1670. PubMed ID: 33535796 [Abstract] [Full Text] [Related]
24. Prostate-specific membrane antigen radioguided surgery with negative histopathology: an in-depth analysis. Koehler D, Trappe S, Shenas F, Karimzadeh A, Apostolova I, Klutmann S, Ambrosini F, Budäus L, Falkenbach F, Knipper S, Maurer T. Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):548-557. PubMed ID: 37750908 [Abstract] [Full Text] [Related]
25. Targeted salvage lymphadenectomy in patients treated with radical prostatectomy with biochemical recurrence: complete biochemical response without adjuvant therapy in patients with low volume lymph node recurrence over a long-term follow-up. Winter A, Henke RP, Wawroschek F. BMC Urol; 2015 Feb 21; 15(1):10. PubMed ID: 25881245 [Abstract] [Full Text] [Related]
26. Feasibility of Using a Novel Drop-In Gamma Probe for 99m Tc-PSMA-I&S-Guided Lymph Node Detection During Robot-Assisted Radical Prostatectomy for Primary Prostate Cancer. Harke NN, Fuhrmann C, Czerner C, Rudolf F, Ross TL, Katzendorn O, Bengel F, Kuczyk MA, Weiberg D, Derlin T. Clin Nucl Med; 2024 Oct 01; 49(10):948-952. PubMed ID: 38968541 [Abstract] [Full Text] [Related]
30. Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer. Maurer T, Weirich G, Schottelius M, Weineisen M, Frisch B, Okur A, Kübler H, Thalgott M, Navab N, Schwaiger M, Wester HJ, Gschwend JE, Eiber M. Eur Urol; 2015 Sep 01; 68(3):530-4. PubMed ID: 25957851 [Abstract] [Full Text] [Related]
35. Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer. Robu S, Schottelius M, Eiber M, Maurer T, Gschwend J, Schwaiger M, Wester HJ. J Nucl Med; 2017 Feb 01; 58(2):235-242. PubMed ID: 27635024 [Abstract] [Full Text] [Related]
36. [Diagnostic performance of 68GA-PSMA PET/CTin patients with prostate cancer]. Veliev EI, Tomilov AA, Goncharuk DA, Bogdanov AB, Golubtsova EN. Urologiia; 2018 Jul 01; (3):105-110. PubMed ID: 30035428 [Abstract] [Full Text] [Related]